logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10543179 B1

PDFFull Text
Date of Patent:
Jan. 28, 2020

Filed:

May. 23, 2018

Dosage regimen of an s1p receptor modulator

Applicant:

Novartis Ag, Basel, CH;

Inventors:

Craig Boulton, Horsham, GB;

Pascale Burtin, Huningue, FR;

Olivier David, Mulhouse, FR;

Ana de Vera, Basel, CH;

Thomas Dumortier, Basel, CH;

Irene Hunt, Basel, CH;

Robert Schmouder, Berkeley Heights, NJ (US);

William C. Collins, Basel, CH;

Assignee:

Other;

Attorney:

Baker Donelson

Primary Examiner:

David Browe

Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01); G06F 19/00 (2018.01); A61K 31/138 (2006.01); A61K 31/661 (2006.01); A61K 45/06 (2006.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01); A61B 5/0402 (2006.01); A61B 5/00 (2006.01); G01N 33/487 (2006.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
A61K 31/135 (2013.01); A61B 5/021 (2013.01); A61B 5/024 (2013.01); A61B 5/0402 (2013.01); A61B 5/444 (2013.01); A61B 5/4833 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/661 (2013.01); A61K 45/06 (2013.01); G01N 33/487 (2013.01); G06F 19/326 (2013.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01);
Abstract

The present invention relates to a dosage regimen of an S1P receptor modulator or agonist in the course of the treatment of patients suffering from an inflammatory or autoimmune disorder, for example multiple sclerosis. Specifically, the present invention relates to testing a patient for a history of infection and vaccinating the patient prior to administration of fingolimod or a pharmaceutically acceptable salt thereof at a daily dosage of 0.5 mg.

Find Patent Forward Citations

Boulton, Craig. (2020). Dosage regimen of an s1p receptor modulator (U.S. Patent No. 10543179). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10543179

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…